Compassionate Use of Certolizumab Pegol in Patients with Crohn's Disease Who Have Failed Previous TNF Inhibitor Therapies

被引：0
|
作者：
Vermeire, Severine [1 ]
Howaldt, Stefanie
Hommes, Daan [2 ]
Bressler, Brian [3 ]
Colombel, Jean-Frederic [4 ]
Mitchev, Krassimir [5 ]
Rutgeerts, Paul [1 ]
机构：
[1] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[2] Leiden Univ, Leiden, Netherlands
[3] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada
[4] Hop Claude Huriez, Lille, France
[5] UCB, Briane Lalleud, Belgium
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷
关键词：
D O I：
10.14309/00000434-201010001-01149
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1149
引用
收藏
页码：S416 / S416
页数：1
相关论文
共 50 条
  • [1] Certolizumab pegol in patients with Crohn's disease who failed treatment with other anti-TNFs: data from a compassionate use program
    Vermeire, S.
    Collin, B.
    Mitchev, K.
    Howaldt, S.
    Hommes, D.
    Rutgeerts, P.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S29 - S29
  • [2] CERTOLIZUMAB PEGOL IN PATIENTS WITH CROHN'S DISEASE: A LONG TERM UPDATE OF COMPASSIONATE USE
    Mocciaro, F.
    Renna, S.
    Orlando, A.
    Olivo, M.
    Sinagra, E.
    Cottone, M.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S189 - S189
  • [3] Compassionate use of certolizumab pegol in patients with Crohn's disease for whom treatment with one or two Anti-TNFs failed
    Vermeire, Severine
    Collin, Benoit
    Mitchev, Krassimir
    Howaldt, Stefanie
    Hommes, Daniel W.
    Rutgeerts, Paul J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S484 - S484
  • [4] Certolizumab pegol is efficacious in Crohn's disease patients who have failed infliximab regardless of concomitant therapy or reason for failure
    Abreu, Maria
    Sandborn, William
    D'Haens, Geert
    Colombed, Jean-Frederic
    Mitchev, Krassimir
    Raedler, Andreas
    Lee, Scott
    Fedorak, Richard
    Vermeire, Severine
    Rutgeerts, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S430 - S431
  • [5] Efficacy of intensification therapy with certolizumab pegol in Crohn's disease patients included in a compassionate-use program
    Fernandez-Blanco, Ignacio
    Hinojosa, Joaquin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S427 - S427
  • [6] Efficacy and safety of certolizumab pegol in Crohn's disease patients with loss of response or intolerance to previous anti-TNF
    Ferrer Bradley, I.
    Marin, I.
    Maroto, N.
    Mora, M.
    Hinojosa, E.
    Lopez, B.
    Menchen, L.
    Hinojosa, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S276 - S276
  • [7] Certolizumab pegol: A guide to its use in Crohn's disease
    不详
    Drugs & Therapy Perspectives, 2007, 23 (11) : 5 - 8
  • [8] Efficacy of Certolizumab Pegol Therapy in Patients With Crohn's Disease
    Shafran, Ira
    Al-Maani, Sayel
    Burgunder, Patricia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S451 - S451
  • [9] Certolizumab pegol therapy in a patient with Crohn's disease with previous loss of response to 2 anti-TNF agents
    Domenech, Eugeni
    Cabriada, Jose Luis
    Bernal, Antonio
    Cara, Carlos
    Gassull, Miguel Angel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S429 - S429
  • [10] SUCCESSFUL INDUCTION OF CLINICAL RESPONSE AND REMISSION WITH CERTOLIZUMAB PEGOL CROHN'S DISEASE PATIENTS: A MULTI-CENTER EXPERIENCE OF COMPASSIONATE USE
    Danese, S.
    Mocciaro, F.
    Guidi, L.
    Scribano, M. L.
    Comberlato, M.
    Vangeli, M.
    Stefanelli, T.
    Pulitano, R.
    Manca, A.
    Armuzzi, A.
    Malesci, A.
    Prantera, C.
    Cottone, M.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S69 - S69
12345